Results 11 to 20 of about 1,478,450 (299)

Antibody Levels at 3-Years Follow-Up of a Third Dose of Measles-Mumps-Rubella Vaccine in Young Adults

open access: yesVaccines, 2022
Mumps outbreaks and breakthrough infections of measles and rubella have raised concerns about waning of vaccine-induced immunity after two doses of measles-mumps-rubella (MMR) vaccination.
Patricia Kaaijk   +7 more
doaj   +1 more source

Factors influencing the SARS-CoV-2 infection and vaccination induced immune response in rheumatoid arthritis

open access: yesFrontiers in Immunology, 2022
BackgroundTo investigate the factors that have significant impact on the Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) infection and vaccination induced immune response in rheumatoid arthritis (RA).MethodsSerological response was measured
Dora Nemeth   +15 more
doaj   +1 more source

Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France

open access: yesEBioMedicine, 2021
Background: Children are underrepresented in the COVID-19 pandemic and often experience milder disease than adolescents and adults. Reduced severity is possibly due to recent and more frequent seasonal human coronaviruses (HCoV) infections.
Tom Woudenberg   +37 more
doaj   +1 more source

CXCR5+CD8+ T Cells Shape Antibody Responses In Vivo Following Protein Immunisation and Peripheral Viral Infection

open access: yesFrontiers in Immunology, 2021
Crosstalk between T and B cells is crucial for generating high-affinity, class-switched antibody responses. The roles of CD4+ T cells in this process have been well-characterised.
Timona S. Tyllis   +9 more
doaj   +1 more source

Extrafollicular antibody responses

open access: yesImmunological Reviews, 2003
Summary:  In adaptive antibody responses, B cells are induced to grow either in follicles where they form germinal centers or in extrafollicular foci as plasmablasts. Extrafollicular growth typically occurs in the medullary cords of lymph nodes and in foci in the red pulp of the spleen.
MacLennan, Ian CM   +7 more
openaire   +3 more sources

Humoral Response Induced by Prime-Boost Vaccination with the ChAdOx1 nCoV-19 and mRNA BNT162b2 Vaccines in a Teriflunomide-Treated Multiple Sclerosis Patient

open access: yesVaccines, 2021
Patients with multiple sclerosis (MS) are treated with drugs that may impact immune responses to SARS-CoV-2 vaccination. Evaluation of “prime-boost” (heterologous) vaccination regimens including a first administration of a viral vector-based vaccine and ...
Yves Michiels   +4 more
doaj   +1 more source

Paper-based RNA detection and multiplexed analysis for Ebola virus diagnostics

open access: yesScientific Reports, 2017
The most performing techniques enabling early diagnosis of infectious diseases rely on nucleic acid detection. Today, because of their high technicality and cost, nucleic acid amplification tests (NAAT) are of benefit only to a small fraction of ...
Laura Magro   +10 more
doaj   +1 more source

Blood Antibody Titers and Adverse Reactions after BNT162b2 mRNA Vaccination

open access: yesVaccines, 2022
This study aimed to measure, considering a prior history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (SCV-negative/positive), antibodies titer using Elecsys Anti-SARS-CoV-2 S immunoassay (Roche Diagnostics, Mannheim, Germany)
Jolanta Kiewisz   +4 more
doaj   +1 more source

COVID-19 Vaccination in Health Care Workers in Italy: A Literature Review and a Report from a Comprehensive Cancer Center

open access: yesVaccines, 2022
The coronavirus disease 2019 pandemic still represents a global public health emergency, despite the availability of different types of vaccines that reduced the number of severe cases, the hospitalization rate and mortality.
Chiara Maura Ciniselli   +8 more
doaj   +1 more source

Influenza Vaccine-Induced Antibody Responses Are Not Impaired by Frailty in the Community-Dwelling Elderly With Natural Influenza Exposure

open access: yesFrontiers in Immunology, 2018
Background: Elderly adults over 65 years of age are recommended to receive seasonal influenza vaccination as they are at a higher risk of infection and its complications than the younger community.
Vipin Narang   +16 more
doaj   +1 more source

Home - About - Disclaimer - Privacy